You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 17, 2024

CLINICAL TRIALS PROFILE FOR ADIPEX-P


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for ADIPEX-P

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00771654 ↗ Phentermine/Gastric Band Weight Loss Study Withdrawn Atrium Health N/A 2009-02-01 This is a prospective, randomized, double-blind controlled trial. The goal is to show whether the administration of daily oral Phentermine will augment patient weight loss and resolve obesity associated comorbidities following gastric band operation.
NCT00771654 ↗ Phentermine/Gastric Band Weight Loss Study Withdrawn Carolinas Healthcare System N/A 2009-02-01 This is a prospective, randomized, double-blind controlled trial. The goal is to show whether the administration of daily oral Phentermine will augment patient weight loss and resolve obesity associated comorbidities following gastric band operation.
NCT01886937 ↗ Studying the Effects of Phentermine on Eating Behavior Completed AstraZeneca Phase 4 2012-07-01 The goal of this study is to determine whether one week of phentermine compared to placebo administration results in changes in food intake during a laboratory meal.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for ADIPEX-P

Condition Name

Condition Name for ADIPEX-P
Intervention Trials
Obesity 2
Cocaine Use Disorder 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for ADIPEX-P
Intervention Trials
Cocaine-Related Disorders 1
Weight Loss 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for ADIPEX-P

Trials by Country

Trials by Country for ADIPEX-P
Location Trials
United States 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for ADIPEX-P
Location Trials
Kentucky 1
New York 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for ADIPEX-P

Clinical Trial Phase

Clinical Trial Phase for ADIPEX-P
Clinical Trial Phase Trials
Phase 4 1
Phase 1 1
N/A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for ADIPEX-P
Clinical Trial Phase Trials
Completed 2
Withdrawn 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ADIPEX-P

Sponsor Name

Sponsor Name for ADIPEX-P
Sponsor Trials
New York State Psychiatric Institute 1
National Institute on Drug Abuse (NIDA) 1
University of Kentucky 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for ADIPEX-P
Sponsor Trials
Other 4
Industry 1
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.